Thomas M Zollner on OCEANIC-STROKE Study: Amazingly Good News for Patients With Stroke
Thomas M Zollner, Reproductive Health Cluster Lead at Bayer, reposted from Alexander Krupp on LinkedIn:
”Amazingly good news for patients with stroke: The Phase III study OCEANIC-STROKE in secondary stroke prevention met its primary endpoint.
Asundexian 50 mg once daily significantly reduced the risk of ischemic stroke compared to placebo, both in combination with antiplatelet therapy, in patients after a non-cardioembolic ischemic stroke or high-risk ischemic attack.
OCEANIC-STROKE is the first successfully completed Phase III study of a FactorXIa Inhibitor.
Each year, approximately 12 million people worldwide will experience a stroke.
Of these, 20-30% will be a recurrent stroke.
Despite available secondary stroke prevention options, the risk of secondary stroke remains high.
One in five stroke survivors will have another stroke within five years.”
Quoting Alexander Krupp‘s post:
”A new medicine was born today: We are just announcing positive results of the OCEANIC STROKE study in secondary stroke prevention.
There a few moments in a worklife when you can be part of a novel medicine being born.
For me, this is today: We are bringing a novel treatment option to millions of patients to reduce the risk of secondary ischemic stroke.
I am humble and honored to be part of such an incredible TeamBayer that has just made the impossible possible, unlocking superpowers in a new operating model DSO.
Thank you!”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly